Common Contracts
3 similar Sales Agreement contracts by Atara Biotherapeutics, Inc., Adaptimmune Therapeutics PLC
ADAPTIMMUNE THERAPEUTICS PLC $200,000,000 AMERICAN DEPOSITARY SHARES each representing 6 Ordinary Shares SALES AGREEMENTSales Agreement • April 8th, 2022 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • New York
Adaptimmune Therapeutics plc (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
Atara Biotherapeutics, Inc. COMMON STOCK SALES AGREEMENTSales Agreement • February 27th, 2020 • Atara Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Atara Biotherapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
Atara Biotherapeutics, Inc. COMMON STOCK SALES AGREEMENTSales Agreement • February 26th, 2019 • Atara Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Atara Biotherapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
